CDK4 and neoplasm: To assess whether the cytotoxic effects of the combined drug treatment are dependent on PML in vivo, we established tumor-bearing nude mice using either control or PML gene-edited MOLM-13 cells and administered CDK4/6i and ATRA (Fig. 6a).